Windtree Therapeutics Inc expected to post a loss of 26 cents a share - Earnings Preview

Windtree Therapeutics

05/11/2022 03:07

* Windtree Therapeutics Inc  WINT.OQ   WINT.O  is expected
to show
a rise in quarterly revenue when it reports  results on November
8 (estimated). 
    * The Warrington Pennsylvania-based  company is expected to
report
revenue of $25 thousand, according to the mean estimate from 2
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Windtree
Therapeutics Inc
is for a loss of 26 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Windtree
Therapeutics Inc is $3​, above​ its last closing price of $0.16.
​​​

This summary was machine generated November 5 at 03:06 GMT.  All
figures in US dollars  unless otherwise stated